Global Health last traded at ₹1,308.00 (2026-10-13). Over the past month the stock moved -10.1%, three months the stock moved +6.4%, year the stock moved -1.6%. Its closing range over 52 weeks is ₹985.30 – ₹1,512.60, with the latest close 13.5% below the high.
Closing prices up to 2026-10-13.
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]
Hospital Count[1] Global Health operates 6 hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, Patna and Noida. Spanning an area of 5.6 million sq. ft., they have 3,435 installed beds as on Sep 30, 2025. They provide healthcare services in over 30 medical specialties and engage 2,000+ doctors led by highly experienced department heads.
In the latest quarter (Jun 2026), Global Health reported sales of ₹1,304.00 crore (+26.5%) and net profit of ₹157.00 crore (-1.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1,304 | 287.00 | 22.00 | 157.00 | 5.90 |
| Mar 2026 | 1,159 | 244.00 | 21.00 | 142.00 | 5.36 |
| Dec 2025 | 1,121 | 217.00 | 19.00 | 95.00 | 3.54 |
| Sep 2025 | 1,099 | 231.00 | 21.00 | 158.00 | 5.89 |
| Jun 2025 | 1,031 | 247.00 | 24.00 | 159.00 | 5.92 |
| Mar 2025 | 931.00 | 225.00 | 24.00 | 101.00 | 3.78 |
| Dec 2024 | 943.00 | 238.00 | 25.00 | 143.00 | 5.32 |
| Sep 2024 | 957.00 | 228.00 | 24.00 | 131.00 | 4.87 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +13.4% | +12.8% | +15.1% | +19.7% | +14.8% | +18.9% | +24.5% | +26.5% |
| Operating profit growth | +7.0% | +10.2% | +25.7% | +32.8% | +1.3% | -8.8% | +8.4% | +16.2% |
| Net profit growth | +4.8% | +15.3% | -20.5% | +50.0% | +20.6% | -33.6% | +40.6% | -1.3% |
| EPS growth | +4.5% | +15.4% | -20.3% | +49.5% | +20.9% | -33.5% | +41.8% | -0.3% |
| OPM % | 24.0% | 25.0% | 24.0% | 24.0% | 21.0% | 19.0% | 21.0% | 22.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Global Health reported sales of ₹4,410.00 crore (+19.4%) and net profit of ₹554.00 crore (+15.2%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 4,410 | 919.00 | 21.00 | 554.00 | 20.70 |
| Mar 2025 | 3,692 | 877.00 | 24.00 | 481.00 | 17.92 |
| Mar 2024 | 3,275 | 809.00 | 25.00 | 478.00 | 17.81 |
| Mar 2023 | 2,710 | 637.00 | 24.00 | 326.00 | 12.16 |
| Mar 2022 | 2,167 | 458.00 | 21.00 | 196.00 | 7.75 |
| Mar 2021 | 1,447 | 197.00 | 14.00 | 29.00 | 5.81 |
| Mar 2020 | 1,500 | 192.00 | 13.00 | 36.00 | 7.36 |
| Mar 2019 | 1,456 | 172.00 | 12.00 | 51.00 | 10.44 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +8.4% | +3.0% | -3.5% | +49.8% | +25.1% | +20.8% | +12.7% | +19.4% |
| Operating profit growth | +37.6% | +11.6% | +2.6% | +132.5% | +39.1% | +27.0% | +8.4% | +4.8% |
| Net profit growth | +54.5% | -29.4% | -19.4% | +575.9% | +66.3% | +46.6% | +0.6% | +15.2% |
| EPS growth | +54.0% | -29.5% | -21.1% | +33.4% | +56.9% | +46.5% | +0.6% | +15.5% |
| OPM % | 12.0% | 13.0% | 14.0% | 21.0% | 24.0% | 25.0% | 24.0% | 21.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Global Health.
Get Free AI Stock Analysis FREE →Global Health acquires 10,560 sq. metre land parcel in Ghaziabad - Business Standard
Global Health declares ₹0.50 per share dividend for FY26 at AGM - scanx.trade
Global Health declares ₹0.50 per share dividend for FY26 at AGM - scanx.trade
Global Health hosts analyst meetings with Polar Capital and Chikara - scanx.trade
Buy Global Health; target of Rs 1750: Prabhudas Lilladher - Moneycontrol.com
Buy Global Health; target of Rs 1750: Prabhudas Lilladher - Moneycontrol.com
Buy Global Health; target of Rs 1750: Prabhudas Lilladher - Moneycontrol.com
Global Health Shares Surge 2.01%, Trading at Rs 1,443.60 - Moneycontrol.com
Global Health Shares Surge 2.01%, Trading at Rs 1,443.60 - Moneycontrol.com
Global Health Shares Rise 2.02%, Among Top Gainers on Nifty Midcap 150 - Moneycontrol.com
Global Health shares were last quoted at ₹1,308.00 (-0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Global Health has a price-to-earnings (P/E) ratio of 72.27 and a price-to-book (P/B) ratio of 9.76. The industry P/E is 101.02.
The 52-week high of Global Health is ₹1,542.00 and the 52-week low is ₹955.20.
The market capitalisation of Global Health is about ₹40,204.85 crore.
In the latest quarter (Jun 2026), Global Health reported sales of ₹1,304.00 crore (+26.5%) and net profit of ₹157.00 crore (-1.3%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Global Health has a 3-year ROE of 16.00%, 3-year profit growth of 20.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 33.00% of Global Health.
Global Health belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z